Skip to main content

and
  1. No Access

    Chapter

    Evaluation of Patients with Lung Cancer

    The purpose of pretreatment evaluation in lung cancer is to determine the best option for the patients. The histopathology and stage of the disease and the patient’s performance status, comorbidities, symptoms...

    Gokcen Ömeroğlu Şimşek, Pınar Çelik, James R. Jett in Airway diseases (2023)

  2. Article

    Open Access

    Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium

    Support for early detection of lung cancer has emerged from the National Lung Screening Trial (NLST), in which low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20 % relative to ch...

    Charles E. Birse, Robert J. Lagier, William FitzHugh, Harvey I. Pass in Clinical Proteomics (2015)

  3. No Access

    Article

    A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

    Weight loss predicts a poor prognosis for patients with non-small-cell lung cancer. Tumor necrosis factor α (TNFα) is a mediator of this weight loss, yet no studies have tested infliximab, an IgG monoclonal an...

    Aminah Jatoi, James R. Jett, Jeff Sloan, Paul Novotny in Supportive Care in Cancer (2004)

  4. No Access

    Article

    Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

    Performance scores predict benefits and toxicities from chemotherapy. Among older cancer patients, however, many investigators have empirically called for a detailed assessment of activities of daily living, c...

    Aminah Jatoi, Shauna Hillman, Philip J. Stella in Supportive Care in Cancer (2003)

  5. No Access

    Article

    The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines

    The antitumor effect of recombinant human tumor necrosis factor (rH-TNF) on two clones of rat fibrosarcoma with different metastatic potential to lymph nodes was examined. The colony formation of clone A, whic...

    Junichi Ishihara, Nagahiro Saijo, Yasutsuna Sasaki in Cancer Immunology, Immunotherapy (1987)

  6. No Access

    Article

    The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines

    The human tumor colony assay was used to evaluate the effect of a new chemotherapeutic agent (KW2152) on colony inhibition of four non-small cell lung cancer cell lines and a mouse cell line. With continuous e...

    James R. Jett, Nagahiro Saijo, Weon-Seon Hong in Investigational New Drugs (1987)

  7. No Access

    Article

    In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin

    The effects of carboplatin and cisplatin on colony formation in stomach and lung cancer cell lines were examined and compared. The colony-inhibitory activity of carboplatin against stomach and lung cancer cell...

    Hidenobu Takahashi, Yasutsuna Sasaki in Cancer Chemotherapy and Pharmacology (1987)

  8. No Access

    Article

    Stage-associated incidence of serum circulating immune complexes in patients with untreated bronchogenic carcinoma

    Serum circulating immune complexes were quantitated by means of a C1q-binding enzyme-linked immunosorbent assay in the serum from 46 untreated bronchogenic carcinoma patients, and the results compared with tho...

    Alejandro Ruiz-Argüelles, James R. Jett in Cancer Immunology, Immunotherapy (1982)

  9. No Access

    Article

    A new immunodeficiency disorder in humans involving NK cells

    Immunodeficiency disorders have provided much information on the development and interaction of the various B and T lymphoid components in the immune system of man. As the lymphoid system becomes increasingly ...

    John C. Roder, Tina Haliotis, Margareta Klein, Stefan Korec, James R. Jett in Nature (1980)

  10. No Access

    Chapter and Conference Paper

    Aryl Hydrocarbon Hydroxylase in Man and Lung Cancer

    Lung cancer is one of the leading causes of cancer deaths in most Western countries. In the United States it accounts for 33% of the cancer deaths in males and 11% of the cancer deaths in females. More males d...

    Gottfried Kellermann in Human Genetic Variation in Response to Med… (1978)